Sanginita Chemicals Gelecekteki Büyüme

Future kriter kontrolleri 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Sanginita Chemicals.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Chemicals kazanç büyümesi	21.0%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Sanginita Chemicals Limited (NSE:SANGINITA) Shares Fly 26% But Investors Aren't Buying For Growth

May 01

Revenues Working Against Sanginita Chemicals Limited's (NSE:SANGINITA) Share Price Following 26% Dive

Mar 11

Sanginita Chemicals Limited (NSE:SANGINITA) Surges 38% Yet Its Low P/S Is No Reason For Excitement

Jan 02

These 4 Measures Indicate That Sanginita Chemicals (NSE:SANGINITA) Is Using Debt Reasonably Well

Dec 30

Sanginita Chemicals Limited's (NSE:SANGINITA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Jan 18

Does Sanginita Chemicals (NSE:SANGINITA) Have A Healthy Balance Sheet?

Nov 26

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Sanginita Chemicals yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

NSEI:SANGINITA - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
9/30/2024	2,005	4	-151	-69	N/A
6/30/2024	1,726	7	N/A	N/A	N/A
3/31/2024	1,515	8	-62	-23	N/A
12/31/2023	1,325	13	N/A	N/A	N/A
9/30/2023	1,367	11	81	102	N/A
6/30/2023	1,334	6	N/A	N/A	N/A
3/31/2023	1,486	4	128	137	N/A
12/31/2022	1,535	0	N/A	N/A	N/A
9/30/2022	1,720	-9	26	29	N/A
6/30/2022	1,918	-3	N/A	N/A	N/A
3/31/2022	1,981	3	-36	-30	N/A
12/31/2021	2,127	7	N/A	N/A	N/A
9/30/2021	1,977	12	47	53	N/A
6/30/2021	1,953	17	N/A	N/A	N/A
3/31/2021	1,648	8	82	85	N/A
12/31/2020	1,486	6	N/A	N/A	N/A
9/30/2020	1,567	20	22	24	N/A
6/30/2020	1,462	24	N/A	N/A	N/A
3/31/2020	1,598	34	-24	-16	N/A
12/31/2019	1,648	50	N/A	N/A	N/A
9/30/2019	1,589	44	N/A	N/A	N/A
6/30/2019	1,748	38	N/A	N/A	N/A
3/31/2019	1,876	39	-3	6	N/A
3/31/2018	1,945	35	N/A	28	N/A
3/31/2017	1,473	11	N/A	-74	N/A
3/31/2016	1,441	11	N/A	2	N/A
3/31/2015	1,286	10	N/A	23	N/A
3/31/2014	1,190	8	N/A	57	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if SANGINITA's forecast earnings growth is above the savings rate (6.7%).

Kazançlar ve Piyasa: Insufficient data to determine if SANGINITA's earnings are forecast to grow faster than the Indian market

Yüksek Büyüme Kazançları: Insufficient data to determine if SANGINITA's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: Insufficient data to determine if SANGINITA's revenue is forecast to grow faster than the Indian market.

Yüksek Büyüme Geliri: Insufficient data to determine if SANGINITA's revenue is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if SANGINITA's Return on Equity is forecast to be high in 3 years time

Sanginita Chemicals Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Second quarter 2025 earnings released

Sanginita Chemicals Limited, Annual General Meeting, Sep 04, 2024

First quarter 2025 earnings released: EPS: ₹0.12 (vs ₹0.20 in 1Q 2024)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

Full year 2024 earnings released: EPS: ₹0.45 (vs ₹0.24 in FY 2023)

Sanginita Chemicals Limited (NSE:SANGINITA) Shares Fly 26% But Investors Aren't Buying For Growth

Investor sentiment improves as stock rises 21%

Revenues Working Against Sanginita Chemicals Limited's (NSE:SANGINITA) Share Price Following 26% Dive

Investor sentiment improves as stock rises 15%

Third quarter 2024 earnings released: EPS: ₹0.26 (vs ₹0.17 in 3Q 2023)

Sanginita Chemicals Limited (NSE:SANGINITA) Surges 38% Yet Its Low P/S Is No Reason For Excitement

These 4 Measures Indicate That Sanginita Chemicals (NSE:SANGINITA) Is Using Debt Reasonably Well

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: EPS: ₹0.32 (vs ₹0.04 in 2Q 2023)

Investor sentiment improves as stock rises 15%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Sanginita Chemicals (NSE:SANGINITA) Seems To Use Debt Quite Sensibly

First quarter 2024 earnings released: EPS: ₹0.20 (vs ₹0.09 in 1Q 2023)

Whole-Time Director recently sold ₹684k worth of stock

Full year 2023 earnings released: EPS: ₹0.24 (vs ₹0.20 in FY 2022)

Third quarter 2023 earnings released: EPS: ₹0.17 (vs ₹0.52 loss in 3Q 2022)

Is Sanginita Chemicals (NSE:SANGINITA) Using Too Much Debt?

Insufficient new directors

Second quarter 2023 earnings released: EPS: ₹0.04 (vs ₹0.41 in 2Q 2022)

Insider recently sold ₹241k worth of stock

Whole-Time Director recently sold ₹1.9m worth of stock

First quarter 2023 earnings released: EPS: ₹0.09 (vs ₹0.46 in 1Q 2022)

Insufficient new directors

Insider recently sold ₹825k worth of stock

Full year 2022 earnings released: EPS: ₹0.20 (vs ₹0.44 in FY 2021)

Investor sentiment improved over the past week

We Think Sanginita Chemicals (NSE:SANGINITA) Is Taking Some Risk With Its Debt

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Insider recently sold ₹3.5m worth of stock

Second quarter 2022 earnings released: EPS ₹0.41 (vs ₹0.72 in 2Q 2021)

Investor sentiment improved over the past week

Non-Executive Director recently sold ₹1.7m worth of stock

Investor sentiment improved over the past week

Non-Executive Director recently sold ₹1.7m worth of stock

Sanginita Chemicals (NSE:SANGINITA) Has A Somewhat Strained Balance Sheet

First quarter 2022 earnings released: EPS ₹0.46 (vs ₹0.10 loss in 1Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Is Sanginita Chemicals (NSE:SANGINITA) Using Too Much Debt?

New 90-day low: ₹24.90

Third quarter 2021 earnings released: ₹0.15 loss per share (vs ₹0.72 profit in 3Q 2020)

Sanginita Chemicals Limited's (NSE:SANGINITA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Market pulls back on stock over the past week

Does Sanginita Chemicals (NSE:SANGINITA) Have A Healthy Balance Sheet?

Market bids up stock over the past week

Market pulls back on stock over the past week

New 90-day low: ₹50.20

New 90-day low: ₹64.10

Sanginita Chemicals Limited to Report Q1, 2021 Results on Sep 01, 2020

First quarter earnings released

New 90-day low - ₹74.15

Sanginita Chemicals Limited to Report Q4, 2020 Results on Jun 18, 2020

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin